Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...
A new study published in the Journal of Autism and Developmental Disorders suggests that the ability to comprehend complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback